Comment. There was an immediate decline in the incidence of early-stage prostate cancer tumors among men 75 years and older after the USPSTF recommended against screening this group. The magnitude of the decline was larger than the secular decline in the incidence rate for other stage and age groups. The results are consistent with the hypothesis that the revision of the USPSTF recommendations led to a small to moderate decline in prostate cancer screening rates. Many men 75 years and older may continue to receive screening tests. Some of the decline in the incidence of late-stage tumors may be attributable to decreases in screening via digital rectal examinations.
Prasad et al 3 report that there was no change in selfreported prostate-specific antigen (PSA) screening rates between the 2005 and 2010 National Health Interview Surveys. Self-reported PSA testing measures have poor sensitivity and specificity. 4, 5 Small physician surveys indicate that 20% to 30% of physicians do not always discuss PSA screening with patients prior to ordering tests. 6, 7 Physicians who discontinued prostate cancer screening for all men 75 years and older may not have discussed the decision with patients. A snapshot of self-reported PSA testing rates may lack sensitivity to detect small to moderate changes in screening patterns. Based on trends in prostate cancer incidence rates, the impact of the revised USPSTF recommendation on screening rates merits further investigation. 
EDITOR'S NOTE Time to Stop Screening for Prostate Cancer
O ver the last decade, the evidence that screening for prostate cancer causes more harm than good has grown so much that the US Preventive Services Task Force recommended in 2008 against screening for prostate cancer in men 75 years or older, and more recently, recommended against screening men of any age. The data in the Research Letter by Howard suggest that many physicians agree with the recommendation not to screen older men. Given that the harms of screening (eg, false-positive results, increased worry, treatment-related morbidities such as incontinence and erectile dysfunction) outweigh the benefits for younger men as well, we hope to see a similar decrease in early prostate cancer incidence in young men.
COMMENTS AND OPINIONS
Advance Care Planning of the Acutely Unwell Patient I n a recent article, Stelfox et al 1 make an important observation that when less intensive care unit (ICU) beds are available, the decisions to change patients' goals of care to a more conservative approach increases. This appears to be a response to the lack of ICU facilities rather than an active decision. When it is deemed unlikely to avert death, and death is imminent, our duty to provide patients with supportive care is no less important than our duty to save lives. Advance care planning and any decision to palliate should not be viewed as an option arising from the lack of resources. This requires adequate recognition and training.
The 2009 National Confidential Enquiry into Patient Outcome and Death (NCEPOD) reported that approximately half of all deaths occurring within 96 hours of admission to United Kingdom (UK) hospitals occurred in patients for whom survival was deemed unlikely. A donot-attempt-resuscitation order was lacking in almost a 
